Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors during the central anxious procedure, conolidine modulates alternate molecular targets. A Science Innovations study uncovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide ava... https://jamesj224dyr0.wikilentillas.com/user